06160.HK
BeOne Medicines AG
HKSE · Healthcare · Biotechnology · CH
HKD 220.80
+1.19%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- HKD 1.15
- Revenue estimate
- HKD 13.8B
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- HKD 1.24
- EPS estimate
- HKD 1.00
- Revenue actual
- HKD 13.4B
- Revenue estimate
- HKD 12.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +24.0%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026